Meningitis B Outbreak in Kent: What to Know

The recent outbreak of Meningitis B (MenB) in Kent has raised understandable concern among families, students, and the wider public. While health authorities have confirmed that the outbreak is currently localised, it serves as an important reminder of how serious meningococcal disease can be—and why awareness, early recognition, and vaccination are so important.

In this article, we explain everything you need to know about meningitis B, the current situation in Kent, who is at risk, and what to do if you are considering vaccination—especially given current supply constraints

What Is Meningitis B?

Meningitis B is a type of invasive meningococcal disease (IMD) caused by the bacterium Neisseria meningitidis. It can lead to:

• Meningitis (inflammation of the lining of the brain and spinal cord)
• Septicaemia (life-threatening blood infection)

Although some people carry the bacteria harmlessly in their nose or throat, in rare cases it can invade the bloodstream and cause severe illness very quickly.

Meningitis B is currently the most common strain of meningococcal disease in the UK, despite the success of other vaccination programmes.

How Meningitis B Spreads?

Meningococcal bacteria are spread through close, prolonged contact, such as:

• Kissing
• Sharing drinks or utensils
• Living in close quarters (e.g. university halls)
• Coughing or sneezing in close proximity

This explains why outbreaks are often seen in

• Students
• Teenagers and young adults
• People in shared accommodation

Symptoms: What to Watch For?

Meningitis B can develop rapidly and become life-threatening within hours. Early recognition is critical.

Common symptoms include:

• High fever
• Severe headache
• Neck stiffness
• Sensitivity to light
• Nausea and vomiting
• Cold hands and feet, limb pain
• Pale or mottled skin

Serious warning signs:

• Confusion or difficulty waking
• Seizures
• Rapid breathing
• A non-blanching rash (does not fade under pressure)

Important: The rash is often a late symptom—do not wait for it to appear.

If you suspect meningitis, seek emergency medical care immediately.

Meningitis B Vaccine: How It Works

The MenB vaccine provides protection against many strains of meningococcal group B bacteria. In the UK :

• Introduced into the routine schedule in 2015
• Given to infants at:
  • 8 weeks
  • 12 weeks
  • Booster at 12–13 months

The vaccine is highly effective, particularly in young children, although it does not cover every strain.

Vaccine Limitations

Its important to understand that

• The MenB vaccine reduces the risk of illness
• It does not fully prevent carriage or transmission
• Protection is strongest after two or more doses

This is why, during outbreaks, public health teams combine targeted vaccination (to protect individuals at risk) and antibiotics ( to reduce the spread).

Current Situation: MenB Vaccine Availability

Due to increased demand following the Kent outbreak, MenB vaccine supplies are currently limited in many private clinics.

Immediate appointments may not be available as stock shortages are affecting availability nationwide. Thus, OUR GP are operating waiting lists for MenB vaccinations clinic currently.

Join the Waiting List for MenB Vaccination

If you would like to protect yourself or your family, we recommend registering your interest as soon as possible by visit www.ourgp.co.uk or contact us at +44 7857 761328. Our Team will

• Notify you when stock becomes available
• Prioritise appointments based on clinical need
• Provide expert guidance on vaccination suitability